Symptomatic response to GERDOFF ® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study.
CONCLUSION: GERDOFF® could effectively treat GER symptoms in patients not responding to PPI or alginate-based formulation. ISRCTN_15143752.
PMID: 32721918 [PubMed - in process]
Source: The Turkish Journal of Gastroenterology - Category: Gastroenterology Authors: Boarino V, Raguzzi I, Marocchi M, Merighi A Tags: Turk J Gastroenterol Source Type: research
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Heartburn | Medical Devices | Proton Pump Inhibitors PPIs | Study | Turkey Health